These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21216233)

  • 21. Short-chain fatty acid receptors involved in epithelial acetylcholine release in rat caecum.
    Ballout J; Akiba Y; Kaunitz JD; Diener M
    Eur J Pharmacol; 2021 Sep; 906():174292. PubMed ID: 34216575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterisation of small molecule ligands 4CMTB and 2CTAP as modulators of human FFA2 receptor signalling.
    Schofield ZV; Croker D; Robertson AAB; Massey NL; Donovan C; Tee E; Edwards D; Woodruff TM; Halai R; Hansbro PM; Cooper MA
    Sci Rep; 2018 Dec; 8(1):17819. PubMed ID: 30546040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators.
    Grundmann M; Bender E; Schamberger J; Eitner F
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Free fatty acid receptors: structural models and elucidation of ligand binding interactions.
    Tikhonova IG; Poerio E
    BMC Struct Biol; 2015 Sep; 15():16. PubMed ID: 26346819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemogenetics defines receptor-mediated functions of short chain free fatty acids.
    Bolognini D; Barki N; Butcher AJ; Hudson BD; Sergeev E; Molloy C; Moss CE; Bradley SJ; Le Gouill C; Bouvier M; Tobin AB; Milligan G
    Nat Chem Biol; 2019 May; 15(5):489-498. PubMed ID: 30992568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Homology modeling of FFA2 identifies novel agonists that potentiate insulin secretion.
    Villa SR; Mishra RK; Zapater JL; Priyadarshini M; Gilchrist A; Mancebo H; Schiltz GE; Layden BT
    J Investig Med; 2017 Dec; 65(8):1116-1124. PubMed ID: 28784695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Signaling of free fatty acid receptors 2 and 3 differs in colonic mucosa following selective agonism or coagonism by luminal propionate.
    Tough IR; Forbes S; Cox HM
    Neurogastroenterol Motil; 2018 Dec; 30(12):e13454. PubMed ID: 30136343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Pharmacology and Function of Receptors for Short-Chain Fatty Acids.
    Bolognini D; Tobin AB; Milligan G; Moss CE
    Mol Pharmacol; 2016 Mar; 89(3):388-98. PubMed ID: 26719580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-chain free fatty acid receptors FFA2/GPR43 and FFA3/GPR41 as new potential therapeutic targets.
    Ulven T
    Front Endocrinol (Lausanne); 2012; 3():111. PubMed ID: 23060857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of a Potent Thiazolidine Free Fatty Acid Receptor 2 Agonist with Favorable Pharmacokinetic Properties.
    Hansen AH; Sergeev E; Bolognini D; Sprenger RR; Ekberg JH; Ejsing CS; McKenzie CJ; Rexen Ulven E; Milligan G; Ulven T
    J Med Chem; 2018 Nov; 61(21):9534-9550. PubMed ID: 30247908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-chain fatty acid mitigates adenine-induced chronic kidney disease via FFA2 and FFA3 pathways.
    Mikami D; Kobayashi M; Uwada J; Yazawa T; Kamiyama K; Nishimori K; Nishikawa Y; Nishikawa S; Yokoi S; Kimura H; Kimura I; Taniguchi T; Iwano M
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Jun; 1865(6):158666. PubMed ID: 32061840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation.
    Le Poul E; Loison C; Struyf S; Springael JY; Lannoy V; Decobecq ME; Brezillon S; Dupriez V; Vassart G; Van Damme J; Parmentier M; Detheux M
    J Biol Chem; 2003 Jul; 278(28):25481-9. PubMed ID: 12711604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interdependent allosteric free fatty acid receptor 2 modulators synergistically induce functional selective activation and desensitization in neutrophils.
    Lind S; Holdfeldt A; Mårtensson J; Sundqvist M; Kenakin TP; Björkman L; Forsman H; Dahlgren C
    Biochim Biophys Acta Mol Cell Res; 2020 Jun; 1867(6):118689. PubMed ID: 32092308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The short-chain fatty acid receptor, FFA2, contributes to gestational glucose homeostasis.
    Fuller M; Priyadarshini M; Gibbons SM; Angueira AR; Brodsky M; Hayes MG; Kovatcheva-Datchary P; Bäckhed F; Gilbert JA; Lowe WL; Layden BT
    Am J Physiol Endocrinol Metab; 2015 Nov; 309(10):E840-51. PubMed ID: 26394664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of GPCR Structures for Modelling of Free Fatty Acid Receptors.
    Tikhonova IG
    Handb Exp Pharmacol; 2017; 236():57-77. PubMed ID: 27757764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Quantitative Characterization of Functional Allosteric Effects.
    Kenakin T
    Curr Protoc Pharmacol; 2017 Mar; 76():9.22.1-9.22.10. PubMed ID: 28306151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The therapeutic potential of allosteric ligands for free fatty acid sensitive GPCRs.
    Hudson BD; Ulven T; Milligan G
    Curr Top Med Chem; 2013; 13(1):14-25. PubMed ID: 23409763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and Characterization of a Fluorescent Tracer for the Free Fatty Acid Receptor 2 (FFA2/GPR43).
    Hansen AH; Sergeev E; Pandey SK; Hudson BD; Christiansen E; Milligan G; Ulven T
    J Med Chem; 2017 Jul; 60(13):5638-5645. PubMed ID: 28570808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-chain fatty acids, GPR41 and GPR43 ligands, inhibit TNF-α-induced MCP-1 expression by modulating p38 and JNK signaling pathways in human renal cortical epithelial cells.
    Kobayashi M; Mikami D; Kimura H; Kamiyama K; Morikawa Y; Yokoi S; Kasuno K; Takahashi N; Taniguchi T; Iwano M
    Biochem Biophys Res Commun; 2017 Apr; 486(2):499-505. PubMed ID: 28322790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Specificity and Broad Multitarget Properties of Ligands for the Free Fatty Acid Receptors FFA3/GPR41 and FFA2/GPR43 and the Related Hydroxycarboxylic Acid Receptor HCA2/GPR109A.
    Bisenieks E; Vigante B; Petrovska R; Turovska B; Muhamadejev R; Soloduns V; Velena A; Pajuste K; Saso L; Klovins J; Duburs G; Mandrika I
    Pharmaceuticals (Basel); 2021 Sep; 14(10):. PubMed ID: 34681211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.